local_hospital

Centre Hospitalier Universitaire de la Guadeloupe

Address
Route De Chauvel, 97139 Pointe A Pitre, France

Neoplasms and Urologic Oncology

The Centre Hospitalier Universitaire de la Guadeloupe is conducting clinical research focused on prostatic adenocarcinoma with a high risk of recurrence. This work is centered on cancer treatment, with the goal of understanding whether additional hormonal therapy can help improve long-term outcomes after surgery and reduce the chance of disease returning.

  • Study of prostate cancer after radical prostatectomy
  • Evaluation of adjuvant hormonal treatment for preventing recurrence
  • Focus on long-term survival without metastases

This area of research reflects a strong interest in improving treatment effectiveness for patients with aggressive genitourinary cancers through better post-surgical care.

Virus Diseases and HIV Research

At the Ambulatory Medicine Platform, another key research theme is HIV care. The trials in this area aim to assess whether simplified antiretroviral therapy can maintain viral control in people whose infection is already well managed, supporting efforts to make treatment easier while preserving effectiveness.

  • Research in HIV and long-term viral suppression
  • Comparison of treatment approaches for maintaining virological success
  • Focus on improving treatment convenience without losing control of infection

These studies contribute to ongoing efforts in infectious disease care by exploring practical options for stable patients living with HIV.

Site Overview

assignment
9
connected trials
corporate_fare
10
sponsors
science
18
IMPs

Activity Indicator

Last 6 months

0
Trials started
-100% vs previous period.
2
Trials started 6–12 months ago
9
Total trials linked
Active
trending_downDeclining-100%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 5 of 10 therapeutic areas and 15 of 18 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
7
Sponsors (total)
10
Active sponsors
8

Sponsor Network

Top 8 by active trials.

lock +7 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 978 other sites in France

description
Trial volume
9
Outperforms 72% of sites
public
Therapeutic diversity
10areas
Outperforms 84% of sites
groups
Sponsor diversity
10sponsors
Outperforms 77% of sites

Therapeutic Area Benchmark — France

Select a therapeutic area to compare against other sites in France.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: France

Market Share

Country: France

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Centre Hospitalier Universitaire de la Guadeloupe

lock Showing 1 of 9 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A Randomized Controlled Trial Comparing Azithromycin and Clarithromycin in Mycobacterium Avium Complex Pulmonary Disease TreatmentCentre Hospitalier Universitaire Amiens PicardiePhase IIIRecruitingFeb 2018

IMP list

lock Showing 1 of 18 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Acetylsalicylic Acid1Unknown2019-06-262019-06-26

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.